JP2002516608A - ニガウリの経口活性画分、その活性ペプチドおよび糖尿病治療におけるその使用 - Google Patents
ニガウリの経口活性画分、その活性ペプチドおよび糖尿病治療におけるその使用Info
- Publication number
- JP2002516608A JP2002516608A JP54197198A JP54197198A JP2002516608A JP 2002516608 A JP2002516608 A JP 2002516608A JP 54197198 A JP54197198 A JP 54197198A JP 54197198 A JP54197198 A JP 54197198A JP 2002516608 A JP2002516608 A JP 2002516608A
- Authority
- JP
- Japan
- Prior art keywords
- diabetes
- host
- peptide
- type
- pharmaceutical composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/42—Cucurbitaceae (Cucumber family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/01—Hydrolysed proteins; Derivatives thereof
- A61K38/011—Hydrolysed proteins; Derivatives thereof from plants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Botany (AREA)
- Alternative & Traditional Medicine (AREA)
- Diabetes (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- Medical Informatics (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Endocrinology (AREA)
- Emergency Medicine (AREA)
- Gastroenterology & Hepatology (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Plant Substances (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
Description
Claims (1)
- 【特許請求の範囲】 1.水可溶性組成物MC6 2.SDS-20% PAGE上で単一バンドとして移動することを特徴とする、請求項1 記載の組成物。 3.単一バンドが10kDal末満の分子量を有し、r-インシュリンよりも小さなサイ ズである、請求項2に記載の組成物。 4.3種のペプチドを含む、請求項1に記載の組成物。 5.血糖降下作用を示し経口投与により活性である、請求項1に記載の組成物。 6.SDS-20% PAGEにて10kDal未満の単一バンドとして移動し、3種のペプチド を含み、血糖降下作用を示し、経口投与により活性であることを特徴とする、水 可溶性組成物MC6。 7.生理学的に許容できるビヒクル中にMC6を含む医薬組成物。 8.生理学的に許容できるビヒクルが経口的に許容できるビヒクルである、請求 項7に記載の医薬組成物。 9.経口的に許容できるビヒクルが脱イオン水またはリン酸緩衝生理食塩水を含 む、請求項8に記載の医薬組成物。 10.宿主の血中グルコース濃度を低下させる方法であって、MC6を前記宿主に投 与することを含む前記方法。 11.MC6が生理学的に許容できるビヒクル中に存在している、請求項10に記載の 方法。 12.投与が経口的またはI.V.である、請求項10に記載の方法。 13.宿主が高血糖疾患にかかっている、請求項10に記載の方法。 14.高血糖疾患が糖尿病である、請求項13に記載の方法。 15.糖尿病がI型糖尿病である、請求項14に記載の方法。 16.糖尿病がII型糖尿病である、請求項14に記載の方法、 17.高血糖疾患による哺乳動物宿主の血中グルコース濃度を低減する方法であっ て、前記宿主にMC6の医薬組成物を経口的に投与することを含む、前記方法。 18.哺乳動物宿主がヒトである、請求項17に記載の方法。 19.高血糖疾患が糖尿病である、請求項18に記載の方法。 20.糖尿病がI型糖尿病およびII型糖尿病からなる群より選ばれる、請求項19に 記載の方法。 21.糖尿病による高血糖症であるヒトの血中グルコース濃度を低下させる方法で あって、前記宿主にMC6を含む医薬組成物を経口的に投与することを含む、前記 方法。 22.糖尿病がI型糖尿病およびII型糖尿病からなる群より選ばれる、請求項21に 記載の方法。 23.MC6.1、MC6.2、MC6.3およびMC6.1、MC6.2およびMC6.3のアナログまたは疑似 物からなる群より選ばれるペプチド。 24.以下のアミノ酸配列を有する、請求項23に記載のペプチドMC6.1: K-T-N-M-K-H-M-A-G-A-A-A-A-G-A-V-V-G(配列番号1) 25.以下のアミノ酸配列を有する、請求項23に記載のペプチドMC6.2: K-T-N-M-K-H-M-A-G-A-A(配列番号2) 26.以下のアミノ酸配列を有する、請求項23に記載のペプチドMC6.3: K-T-N-M-K-H-M(配列番号3) 27.ペプチドMC6.1、MC6.2、MC6.3、そのアナログおよび疑似物またはそれらの 混合物を生理学的に許容できるビヒクル中に含む医薬組成物。 28.宿主の血中グルコース濃度を低下させる方法であって、請求項27の医薬組成 物を前記宿主に投与することを含む、前記方法。 29.投与が経口的またはi.v.である、請求項28に記載の方法。 30.宿主が高血糖疾患にかかっている、請求項28に記載の方法。 31.高血糖疾患が糖尿病である、請求項30に記載の方法。 32.糖尿病がI型またはII型糖尿病である、請求項31に記載の方法。
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US83103997A | 1997-04-01 | 1997-04-01 | |
US85085597A | 1997-05-02 | 1997-05-02 | |
US08/850,855 | 1997-05-02 | ||
US08/831,039 | 1997-05-02 | ||
PCT/US1998/006450 WO1998043484A1 (en) | 1997-04-01 | 1998-04-01 | Orally active fraction of momordica charantia, active peptides thereof, and their use in the treatment of diabetes |
Publications (3)
Publication Number | Publication Date |
---|---|
JP2002516608A true JP2002516608A (ja) | 2002-06-04 |
JP2002516608A5 JP2002516608A5 (ja) | 2005-11-24 |
JP4156038B2 JP4156038B2 (ja) | 2008-09-24 |
Family
ID=27125412
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP54197198A Expired - Fee Related JP4156038B2 (ja) | 1997-04-01 | 1998-04-01 | ニガウリの経口活性画分、その活性ペプチドおよび糖尿病治療におけるその使用 |
Country Status (11)
Country | Link |
---|---|
US (3) | US6127338A (ja) |
EP (1) | EP1005274B1 (ja) |
JP (1) | JP4156038B2 (ja) |
KR (1) | KR100509438B1 (ja) |
CN (1) | CN1255044A (ja) |
AT (1) | ATE403672T1 (ja) |
AU (1) | AU749792B2 (ja) |
CA (1) | CA2285452A1 (ja) |
DE (1) | DE69839842D1 (ja) |
ES (1) | ES2310006T3 (ja) |
WO (1) | WO1998043484A1 (ja) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2010124827A (ja) * | 2008-12-01 | 2010-06-10 | China Medical Univ | 血糖値を調整するポリペプチド |
Families Citing this family (25)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN100413884C (zh) * | 1999-04-13 | 2008-08-27 | 普什帕康纳 | 从苦瓜中提取降血糖多肽的方法及其产物和用途 |
US20050136121A1 (en) * | 2003-12-22 | 2005-06-23 | Shear/Kershman Laboratories, Inc. | Oral peptide delivery system with improved bioavailability |
EP1563842A1 (en) * | 2004-02-03 | 2005-08-17 | Novartis AG | Simarouba amara and/or Momordica charantia extracts for the treatment of coccidiosis in poultry |
WO2006030722A1 (ja) * | 2004-09-15 | 2006-03-23 | Yokohama City University | 神経特異的遺伝子発現に必須なアミノ酸配列 |
US8669348B2 (en) * | 2007-03-30 | 2014-03-11 | Aparna Dixit | Anti diabetic protein |
US20100081860A1 (en) * | 2008-04-24 | 2010-04-01 | Searete Llc, A Limited Liability Corporation Of The State Of Delaware | Computational System and Method for Memory Modification |
WO2011032359A1 (zh) * | 2009-09-17 | 2011-03-24 | 中国药科大学 | 苦瓜mc-jj6多肽及其应用与微波促进固相合成方法 |
WO2011032360A1 (zh) * | 2009-09-17 | 2011-03-24 | 中国药科大学 | 苦瓜mc-jj2多肽及其应用与微波促进固相合成方法 |
CN101691394B (zh) * | 2009-09-17 | 2012-05-09 | 中国药科大学 | 微波促进固相合成苦瓜mc-jj6多肽类似物及其应用 |
CN101838309A (zh) * | 2010-05-20 | 2010-09-22 | 中国药科大学 | 微波促进固相合成苦瓜mc-jj0102多肽类似物及其应用 |
CN101830969A (zh) * | 2010-05-20 | 2010-09-15 | 中国药科大学 | 微波促进固相合成苦瓜降血糖mc-jj0104多肽类似物及其应用 |
CN101942010A (zh) * | 2010-05-20 | 2011-01-12 | 中国药科大学 | 微波促进固相合成苦瓜mc-jj0106多肽类似物及其应用 |
CN101824075A (zh) * | 2010-05-20 | 2010-09-08 | 中国药科大学 | 微波促进固相合成苦瓜mc-jj0101多肽类似物及其应用 |
CN101824076A (zh) * | 2010-05-20 | 2010-09-08 | 中国药科大学 | 微波促进固相合成苦瓜mc-jj0105多肽类似物及其应用 |
CN101824074A (zh) * | 2010-05-20 | 2010-09-08 | 中国药科大学 | 微波促进固相合成苦瓜mc-jj0107多肽类似物及其应用 |
CN101824073A (zh) * | 2010-05-20 | 2010-09-08 | 中国药科大学 | 微波促进固相合成苦瓜mc-jj0103多肽类似物及其应用 |
CN101985644B (zh) * | 2010-10-25 | 2013-06-12 | 邹远东 | 一种苦瓜多肽及其制备方法与应用 |
BR112013019251A2 (pt) | 2011-01-28 | 2016-10-11 | Piramal Entpr Ltd | processo para a preparação de um extrato de ervas |
TWI588153B (zh) | 2012-05-18 | 2017-06-21 | 中國醫藥大學 | 多胜肽、編碼該多胜肽之核酸分子、以及該多胜肽之應用 |
CN104650198B (zh) * | 2015-02-09 | 2018-05-08 | 武汉华康臣生物科技有限公司 | 三叉黑顶藻中分离的能治疗糖尿病的活性肽及其用途 |
CN106729606A (zh) * | 2017-01-03 | 2017-05-31 | 河北省农林科学院经济作物研究所 | 苦瓜降糖提取物复合剂及其制备方法 |
CN107412720A (zh) * | 2017-09-15 | 2017-12-01 | 李玉保 | 一种治疗糖尿病的苦瓜多肽复方植物药及其制备方法 |
CN107412721B (zh) * | 2017-09-15 | 2020-11-24 | 李玉保 | 一种降血糖苦瓜多肽复方胶囊及其制备方法 |
CN108707181B (zh) * | 2018-06-14 | 2021-03-12 | 苏秀兰 | 一种抑制肿瘤细胞增殖的苦瓜多肽及其制备方法和应用 |
CN112675292B (zh) * | 2021-01-11 | 2021-11-02 | 中食安泓(广东)健康产业有限公司 | 含有益生菌的制剂在治疗疾病中的应用 |
Family Cites Families (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NL154598B (nl) * | 1970-11-10 | 1977-09-15 | Organon Nv | Werkwijze voor het aantonen en bepalen van laagmoleculire verbindingen en van eiwitten die deze verbindingen specifiek kunnen binden, alsmede testverpakking. |
US3853914A (en) * | 1971-01-11 | 1974-12-10 | Syva Co | Ligand determination of spin labeled compounds by receptor displacement |
US3817837A (en) * | 1971-05-14 | 1974-06-18 | Syva Corp | Enzyme amplification assay |
US3905654A (en) * | 1973-11-14 | 1975-09-16 | Kelsey Hayes Co | Skid control system for dual brake |
US3945988A (en) * | 1974-07-16 | 1976-03-23 | Pushpa Khann | Process for isolation of insulin from plant source |
US4043989A (en) * | 1975-09-11 | 1977-08-23 | Syva Company | Oxazepam derivatives for immunoassay reagents |
US4069105A (en) * | 1977-03-03 | 1978-01-17 | Syva Company | Lidocaine antigens and antibodies |
US4156081A (en) * | 1977-04-15 | 1979-05-22 | Syva Company | Theophylline antigens and antibodies |
JPS57106626A (en) * | 1980-12-22 | 1982-07-02 | Teijin Ltd | Cytotoxic protein complex and its preparation |
US5098710A (en) * | 1987-06-18 | 1992-03-24 | Yaguang Liu | Production of kuguasu |
US5086043A (en) * | 1987-06-18 | 1992-02-04 | Yaguang Liu | Production of Saponins of Lichi |
US4985248A (en) * | 1987-06-18 | 1991-01-15 | Yaguang Liu | Pharmaceutical composition containing a safe extracts of fruits and vegetables for the treating and preventing of diabetes |
CA2124953C (en) * | 1991-12-03 | 2008-02-05 | Robert V. Fishleigh | Peptides related to prion proteins |
US5750361A (en) * | 1995-11-02 | 1998-05-12 | The Regents Of The University Of California | Formation and use of prion protein (PRP) complexes |
-
1998
- 1998-04-01 DE DE69839842T patent/DE69839842D1/de not_active Expired - Fee Related
- 1998-04-01 AT AT98914405T patent/ATE403672T1/de not_active IP Right Cessation
- 1998-04-01 JP JP54197198A patent/JP4156038B2/ja not_active Expired - Fee Related
- 1998-04-01 US US09/053,617 patent/US6127338A/en not_active Expired - Fee Related
- 1998-04-01 AU AU68765/98A patent/AU749792B2/en not_active Ceased
- 1998-04-01 WO PCT/US1998/006450 patent/WO1998043484A1/en active IP Right Grant
- 1998-04-01 CN CN98805001A patent/CN1255044A/zh active Pending
- 1998-04-01 ES ES98914405T patent/ES2310006T3/es not_active Expired - Lifetime
- 1998-04-01 KR KR10-1999-7008994A patent/KR100509438B1/ko not_active IP Right Cessation
- 1998-04-01 CA CA002285452A patent/CA2285452A1/en not_active Abandoned
- 1998-04-01 EP EP98914405A patent/EP1005274B1/en not_active Expired - Lifetime
-
2000
- 2000-07-31 US US09/628,588 patent/US6391854B1/en not_active Expired - Fee Related
-
2002
- 2002-03-21 US US10/101,952 patent/US6852695B2/en not_active Expired - Fee Related
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2010124827A (ja) * | 2008-12-01 | 2010-06-10 | China Medical Univ | 血糖値を調整するポリペプチド |
US8476229B2 (en) | 2008-12-01 | 2013-07-02 | China Medical University | Blood sugar-modulating polypeptides |
Also Published As
Publication number | Publication date |
---|---|
KR100509438B1 (ko) | 2005-08-23 |
CA2285452A1 (en) | 1998-10-08 |
EP1005274A1 (en) | 2000-06-07 |
US6391854B1 (en) | 2002-05-21 |
AU6876598A (en) | 1998-10-22 |
KR20010005917A (ko) | 2001-01-15 |
US20020193310A1 (en) | 2002-12-19 |
ES2310006T3 (es) | 2008-12-16 |
AU749792B2 (en) | 2002-07-04 |
JP4156038B2 (ja) | 2008-09-24 |
EP1005274A4 (en) | 2004-09-08 |
EP1005274B1 (en) | 2008-08-06 |
DE69839842D1 (de) | 2008-09-18 |
CN1255044A (zh) | 2000-05-31 |
US6127338A (en) | 2000-10-03 |
WO1998043484A1 (en) | 1998-10-08 |
US6852695B2 (en) | 2005-02-08 |
ATE403672T1 (de) | 2008-08-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP2002516608A (ja) | ニガウリの経口活性画分、その活性ペプチドおよび糖尿病治療におけるその使用 | |
US7423014B2 (en) | Insulin conjugates for treating diabetes mellitus | |
ZA200406332B (en) | ACC inhibitors. | |
AU2002244020A1 (en) | Methods of treating diabetes mellitus | |
RU2206336C2 (ru) | Фрагмент с-пептида человеческого проинсулина | |
JP6690062B2 (ja) | インスリン含有医薬組成物 | |
JPH10511644A (ja) | アシル化インシュリン類似体 | |
JP2003525846A (ja) | ヒトインスリン誘導体の集合体 | |
WO1997009060A1 (en) | Method of treating insulin resistance | |
CA2224859A1 (en) | Ligand inhibitors of insulin-like growth factor binding proteins and methods of use therefor | |
IE60649B1 (en) | Mixed crystals of insulin and insulin derivatives, a process for the preparation of these mixed crystals, and pharmaceutical agents containing these mixed crystals | |
CA3213261A1 (en) | Gip and glp-1 dual receptor agonist, pharmaceutical composition, and use | |
JP2023539476A (ja) | アネキシンa1のn末端ペプチド製剤及び方法 | |
KR20170069997A (ko) | 미리스토일화된 렙틴-관련된 펩티드 및 이들의 용도 | |
KR102677852B1 (ko) | 글루코스 조절된 구조 전환을 포함하는 인슐린 유사체 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20050401 |
|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20050401 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20070717 |
|
A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20071017 |
|
A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20071126 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20071114 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20080212 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20080512 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20080701 |
|
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20080709 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20110718 Year of fee payment: 3 |
|
R150 | Certificate of patent or registration of utility model |
Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
LAPS | Cancellation because of no payment of annual fees |